Leuprorelin Acetate Microspheres for Injection
Formulation (FDF) · Microspheres for Injection · 3.75mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Leuprorelin Acetate Microspheres for Injection
- Dosage Form
- Microspheres for Injection
- Strength
- 3.75mg
- Therapy Area
- Oncology
- Indication
- Endometriosis; Uterine leiomyoma; Breast cancer; Prostate cancer; Central precocious puberty
- Current Status
- Official FDF licensing catalog (UB161)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3002.15
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price